首页> 美国卫生研究院文献>Oncology Letters >Differential microRNA expression profiles determined by next-generation sequencing in three fulvestrant-resistant human breast cancer cell lines
【2h】

Differential microRNA expression profiles determined by next-generation sequencing in three fulvestrant-resistant human breast cancer cell lines

机译:通过下一代测序在三种耐氟维司特的人乳腺癌细胞系中测定的差异微RNA表达谱

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fulvestrant resistance is a major clinical issue in the treatment of endocrine-based breast cancer. MicroRNAs (miRNAs) are known to serve an important role in tumor chemoresistance. In the present study, the association between miRNA expression profiles and fulvestrant resistance was investigated in human breast cancer cell lines. Three fulvestrant-resistant breast cancer cell lines, namely MCF-7-CC, MCF-7-TT and MCF-7-21, were established using the human breast cancer cell line MCF-7 as the parental cell line and fulvestrant as the screening drug in vitro. Next-generation sequencing was used to determine the miRNA expression profiles in these cell lines. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to determine the biological functions of differentially expressed miRNAs. In total, 1,536 miRNAs were detected in all the samples, including 1,240 known miRNAs and 296 predicted miRNAs. It was observed that the differential miRNA expression profiles varied among the three fulvestrant-resistant cell lines (MCF-7-CC, MCF-7-TT and MCF-7-21), and certain differentially expressed miRNAs were only detected in one or two of the cell lines. A total of 257 miRNAs that were differentially expressed between MCF-7-CC and MCF-7 cells were detected, among which 69 miRNAs were upregulated and 188 miRNAs were downregulated. In addition, 270 miRNAs with significantly different expression between MCF-7-TT and MCF-7 cells were observed, including 180 upregulated and 90 downregulated miRNAs. Between MCF-7-21 and MCF-7 cells, a total of 227 miRNAs were differentially expressed, among which 52 miRNAs were upregulated and 175 miRNAs were downregulated. The miRNAs that were differentially expressed in the three fulvestrant-resistant cell lines as compared with the parental MCF-7 cell line were primarily involved in the following biological processes: Biological regulation, extracellular matrix-receptor interaction, the Notch signaling pathway and focal adhesion. Taken together, the results suggested that miR-143, miR-145, miR-137, miR-424 and miR-21 may serve important roles in fulvestrant resistance in breast cancer. The study findings may provide a basis for further research on the treatment of fulvestrant-resistant breast cancer.
机译:耐氟硅酸酯抗性是治疗内分泌型乳腺癌的主要临床问题。已知MicroRNA(miRNA)在肿瘤化学耐药性中起重要作用。在本研究中,在人类乳腺癌细胞系中研究了miRNA表达谱与氟维司群抗性之间的关联。以人乳腺癌细胞系MCF-7为亲本细胞系,并以氟维司群为筛选剂,建立了三种耐氟维司群的乳腺癌细胞系MCF-7-CC,MCF-7-TT和MCF-7-21。体外药物。下一代测序用于确定这些细胞系中的miRNA表达谱。随后,进行了基因本体论(GO)和《京都议定书》的基因与基因组百科全书(KEGG)途径分析,以确定差异表达的miRNA的生物学功能。在所有样本中总共检测到1,536个miRNA,包括1,240个已知的miRNA和296个预测的miRNA。观察到,三种耐氟维司特抗的细胞系(MCF-7-CC,MCF-7-TT和MCF-7-21)之间的差异性miRNA表达谱有所不同,并且某些差异表达的miRNA仅在一种或两种中检测到细胞系。总共检测到257个在MCF-7-CC和MCF-7细胞之间差异表达的miRNA,其中69个miRNA被上调,而188个miRNA被下调。此外,观察到270个在MCF-7-TT和MCF-7细胞之间表达差异显着的miRNA,包括180个上调的miRNA和90个下调的miRNA。在MCF-7-21和MCF-7细胞之间,总共有227个miRNA差异表达,其中52个miRNA被上调,而175个miRNA被下调。与亲代MCF-7细胞系相比,在三种耐氟维司特抗性细胞系中差异表达的miRNA主要参与以下生物学过程:生物调控,细胞外基质-受体相互作用,Notch信号通路和粘着斑。两者合计,结果表明miR-143,miR-145,miR-137,miR-424和miR-21可能在乳腺癌的氟司韦特耐药中起重要作用。研究结果可能为进一步研究抗氟司韦特的乳腺癌提供基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号